Adagene to join SVB Leerink 11th Annual Global Healthcare Conference

KUALA LUMPUR, Feb 9 -- Adagene Inc (Adagene) announced that members of the company’s management will participate in one-on-one investor meetings and provide a corporate update at the SVB Leerink 11th Annual Global Healthcare Conference, to be held virtually Feb 14-18, 2022.

The presentation is scheduled on Feb 17 at 11.20am (ET). A webcast of the presentation will be accessible in the Investors section of the company’s website for at least 30 days, according to a statement.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.

Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs.

More details at https://www.adagene.com.

-- BERNAMA